I guess some of the recent price weakness is due to this nonsense about Trump changing the US healthcare industry. However, the price seemed to have gotten way ahead of itself prior to that. Obviously they are doing very well and the CEO is extremely bullish. If they keep winning large contracts for the next few years then the high share price doesn't matter but you'd need to have a pretty clear view of the competitive landscape to be confident they can establish and maintain market leadership over that time.
PME Price at posting:
$4.53 Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)